ZFYVE28

Chr 4

zinc finger FYVE-type containing 28

Also known as: LST2, LYST2, lst-2

The protein binds phosphatidylinositol-3-phosphate and negatively regulates epidermal growth factor receptor signaling by promoting receptor degradation in endosomes. Mutations cause spastic tetraplegia with thin corpus callosum and progressive microcephaly, inherited in an autosomal recessive pattern. This gene is highly constrained against loss-of-function variants, suggesting that complete loss of protein function is poorly tolerated.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
2
Pubs (1 yr)
135
P/LP submissions
0%
P/LP missense
0.46
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryZFYVE28
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.26) despite low pLI — interpret in context.
📋
ClinVar Variants
135 unique Pathogenic / Likely Pathogenic· 187 VUS of 361 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.46LOEUF
pLI 0.072
Z-score 4.01
OE 0.26 (0.160.46)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
-0.25Z-score
OE missense 1.03 (0.961.10)
608 obs / 590.9 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.26 (0.160.46)
00.351.4
Missense OE1.03 (0.961.10)
00.61.4
Synonymous OE1.12
01.21.6
LoF obs/exp: 9 / 34.4Missense obs/exp: 608 / 590.9Syn Z: -1.57
DN
0.6744th %ile
GOF
0.72top 25%
LOF
0.3355th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

361 submitted variants in ClinVar

Classification Summary

Pathogenic129
Likely Pathogenic6
VUS187
Likely Benign18
Benign4
129
Pathogenic
6
Likely Pathogenic
187
VUS
18
Likely Benign
4
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
129
0
129
Likely Pathogenic
0
0
6
0
6
VUS
0
174
13
0
187
Likely Benign
0
15
1
2
18
Benign
0
2
0
2
4
Total01911494344

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ZFYVE28 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →